Jay Kailash (544160)

Score breakdown: P/E: 3/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Profit growth of 39.34% far exceeds sales growth of 12.60%, indicating strong margin expansion
• P/E of 5.92 and PEG of 0.23 suggest significant undervaluation relative to earnings growth
• Piotroski F-Score of 7/9 signals solid fundamentals and healthy financial position
• ROCE of 12.07% shows reasonable capital efficiency for a small packaged-foods business

Concerns

• Extremely small market cap of ₹31 crore limits institutional interest and liquidity
• No dividend yield, so total return depends entirely on uncertain future capital appreciation
• Lack of book value, debt/equity, and promoter holding data reduces transparency
• Stock has already risen over 5x from its 52-week low of ₹10.73, raising the risk of over-expectation

AI Analysis

When I look at Jay Kailash, I see a small packaged-foods business selling at a price that makes me pause and think. At ₹61.82, the market cap is just ₹31 crore, and the trailing P/E is 5.92. That is remarkably cheap, especially when profit is growing at 39.34% while sales grow at a more modest 12.60%. The PEG ratio of 0.23 screams undervaluation if the growth is real and sustainable. Graham would ask for a margin of safety, and a P/E of 5.92 certainly provides one — provided the balance sheet is sound. The Piotroski F-Score of 7 out of 9 suggests decent financial health, and ROCE of 12.07% is respectable, though not spectacular. There is no dividend, so the return must come entirely from earnings growth and eventual re-rating. But I have to be honest: this is a micro-cap with no promoter holding data, no book value, and no debt-equity ratio disclosed. That lack of transparency troubles me. The latest quarter shows sales of ₹10 crore and net profit of ₹1 crore, so the profit margin is 10% — acceptable but fragile. Also, the stock has run from ₹10.73 to ₹61.82 in the last 52 weeks, a six-fold jump. Even with low earnings multiples, the market has already taken notice. Could the market be ahead of itself? Or is this just the beginning of a long compounding story? I don't know. The business is simple enough, but a moat is not obvious in packaged foods. I would need to see consistent execution, rising ROCE, and better disclosure before calling it a true Buffett-style stalwart. Right now, it looks like an interesting growth-at-a-low-price situation, but not without risks.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer